BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1350486)

  • 1. Long-term hemodynamic effects of antihypertensive treatment.
    Lund-Johansen P; Omvik P; Nordrehaug JE
    Clin Investig; 1992; 70 Suppl 1():S58-64. PubMed ID: 1350486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T
    Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
    J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P; Myking O
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of multiple action agents in hypertension.
    Lund-Johansen P; Omvik P
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P
    Eur Heart J; 1991 Jun; 12(6):736-40. PubMed ID: 1860471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
    Franz IW; Agrawal B; Wiewel D; Ketelhut R
    Clin Investig; 1992; 70 Suppl 1():S53-7. PubMed ID: 1350485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of carvedilol in hypertension: an update.
    Leonetti G; Egan CG
    Vasc Health Risk Manag; 2012; 8():307-22. PubMed ID: 22661898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
    Frishman WH; Henderson LS; Lukas MA
    Vasc Health Risk Manag; 2008; 4(6):1387-400. PubMed ID: 19337551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W; Agrawal B
    Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
    Moser M; Frishman W
    Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol in hypertension treatment.
    Stafylas PC; Sarafidis PA
    Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.